Tue, 07th Jul 2020 19:05
e-Therapeutics PLC - Oxford-based drug discovery platform - Plans to raise up to GBP12.4 million through placing, subscription and broker option. Shares will be placed at 12 pence each, a 31% discount to Monday closing price.
Current stock price: 17.00p
Year-to-date change: up more than fivefold from 3.10p
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
(Sharecast News) - RNAi medicines data and development specialist e-Therapeutics proposed a fundraise and its delisting from AIM on Wednesday.
(Alliance News) - e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option of listing on ...
e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says 2023 was
e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says that its shares will cease to trade on the OTCQX Best Market i...
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...
E-therapeutics (ETX)